A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations.
| Image |  |
|---|---|
| Description | scientific article published in January 2011 |
| Author/s |
author: Hoon-Kyo Kim |
| Publication date | January 1, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |